UBS Group AG Registered Ordinary Shares (UBS)

Debt Repayment

$0.00

Quarterly · Period ending: · USD

UBS logo

UBS Debt Repayment

Latest reported$0.00
UBS Quarterly Debt Repayment (-$2.39B → $0.00)
High-resolution chart · PNG

UBS debt repayment history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

UBS Group AG Registered Ordinary Shares Debt Repayment — Quarterly (USD)
Period endingDebt Repayment (USD)
0
-5,053,158,650
-8,784,000,000
-5,840,000,000
-451,000,000
-4,772,611,000
-18,186,000,000
-19,679,000,000
-38,601,000,000
-4,775,000,000
-27,341,000,000
-22,156,000,000
1,189,000,000
1,240,000,000
-3,755,000,000
3,719,000,000
-2,008,000,000
7,644,000,000
-6,724,000,000
314,000,000
14,036,000,000
1,787,000,000
654,000,000
9,880,000,000
4,681,000,000
-10,658,000,000
-1,619,000,000
-9,228,000,000
520,000,000
-2,496,901,666
-746,872,980
2,472,944,305
5,203,000,000
-2,589,198,562
6,298,000,000
-1,970,000,000
15,602,032,013
1,812,645,200
-3,195,900,866
2,548,201,414
-1,153,000,000
-6,901,000,000
-4,371,910,164
15,376,069,266
2,822,000,000
732,000,000
7,695,000,000
2,247,784,621
-6,524,827,492
-7,486,025,881
-23,276,191,491
-15,593,814,853
-4,609,070,819
-12,712,230,966
-3,676,206,655
-16,955,989,228
-6,206,453,470
7,079,600,598
6,596,724,184
-9,821,636,696
1,779,204,526
-1,540,447,000
1,339,544,873
1,709,306,985
7,115,989,000
-14,915,368,612
27,834,497,309
-19,931,940,482
-5,583,618,346
10,714,593,000
-33,314,278,000
-28,523,788,000
22,691,066,747
-2,146,235,664
49,266,000,000
-9,606,000,000
34,009,000,000
10,044,327,594
21,337,000,000
-4,002,000,000
17,419,000,000
-18,451,000,000
12,991,000,000
7,175,000,000
33,181,000,000
-18,838,000,000
16,428,000,000
15,609,000,000
10,017,000,000
2,889,000,000
-7,852,000,000
13,300,000,000
-248,000,000
731,000,000
-1,189,000,000
1,161,000,000
905,000,000
1,399,000,000
-1,864,000,000
-658,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.